Corey Tabit to Cost-Benefit Analysis
This is a "connection" page, showing publications Corey Tabit has written about Cost-Benefit Analysis.
Connection Strength
0.057
-
Cost-utility of extracorporeal cardiopulmonary resuscitation in patients with cardiac arrest. Resuscitation. 2019 03; 136:126-130.
Score: 0.034
-
Sample size and cost analysis for pulmonary arterial hypertension drug trials using various imaging modalities to assess right ventricular size and function end points. Circ Cardiovasc Imaging. 2014 Jan; 7(1):115-24.
Score: 0.023